Skip to main content

Table 1 Patient characteristics and days postburn from admission to begin and end of the study periods

From: IGF-I/IGFBP-3 Equilibrates Ratios of Pro- to Anti-inflammatory Cytokines, Which Are Predictors for Organ Function in Severely Burned Pediatric Patients

  Control n = 7 IGF-I/BP-3 n = 17
Age (yrs) 5.7 ± 1.1 6.2 ± 0.8
Gender (F/M) 4/3 10/7
Body weight (kg) 25 ± 3 27 ± 4
Height (cm) 109 ± 11 118 ± 6
TBSA-burn (%) 59 ± 4 55 ± 4
3rd degree-burn (%) 46 ± 6 46 ± 6
Mortality (%) 17 0
Study periods   
Hospital admission (days postburn) 7 ± 2 7 ± 3
Start of study period I (days postburn) 12 ± 3 14 ± 3
End of study period I (days postburn) 17 ± 3 19 ± 3
Start of study period II (days postburn) 24 ± 4 28 ± 3
End of study period II (days postburn) 29 ± 4 33 ± 3
  1. Data presented as means ± SEM. TBSA = total body surface area.